| CCXI Average Annual Return Chart Since 2026 |
| Average Annual Return Benchmarks |
|
Compare CCXI average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| CCXI Share Performance |
| CCXI Average Annual Return Table Since 2026 | ||||||||||||||||||||||||||||||
CCXI average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About ChemoCentryx, Inc. |
| ChemoCentryx is an integrated biopharmaceutical company commercializing and developing new medications for inflammatory and autoimmune diseases and cancer. Co. targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. In the U.S., Co. markets TAVNEOS® (avacopan) as an adjunctive treatment for adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (ANCA-associated vasculitis), specifically granulomatosis with polyangiitis, and microscopic polyangiitis. Co. is also developing TAVNEOS for the treatment of severe Hidradenitis Suppurativa. The CCXI average annual return since 2026 is shown above.
The Average Annual Return on the CCXI average annual return since 2026 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether CCXI average annual return since 2026 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CCXI average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| CCXI Current Stock Quote |
Quotes delayed 20 minutes  Free CCXI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Churchill Capital XI - Class A Ordinary Share (CCXI) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
CDNA Average Annual Return CDRE Average Annual Return CELC Average Annual Return CELU Average Annual Return CELZ Average Annual Return CERS Average Annual Return CGEM Average Annual Return CGEN Average Annual Return CGON Average Annual Return CGTX Average Annual Return More Healthcare companies » |
Video: Don't Forget Dividends in Average Annual Return!